SARS-CoV-2
Showing NaN - NaN of 6
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
Covid19, SARS-CoV-2 Trial in Worldwide (CVnCoV, Placebo, Authorized/licensed vaccines for preventing COVID-19 (AV))
Completed
- Covid19
- SARS-CoV-2
- CVnCoV
- +2 more
-
Buenos Aires, Argentina
- +45 more
Jun 20, 2022
Coronavirus, Covid19, SARS-CoV-2 Trial in Panama city, Lima (CVnCoV 6 µg, CVnCoV 12 µg, Hepatitis A vaccine)
Completed
- Coronavirus
- +3 more
- CVnCoV 6 μg
- +4 more
-
Panama city, Panama
- +1 more
Mar 9, 2022
SARS-CoV-2-specific Immunity in Individuals Who Have Recovered
Active, not recruiting
- SARS-CoV-2
- COVID-19
- Sample collection
-
Birmingham, Alabama
- +52 more
Sep 3, 2021
Advanced Endoscopy During COVID-19
Completed
- Cholangitis, Secondary Biliary
- +5 more
- Endoscopic management according to standard of care
-
Albertson, New York
- +4 more
Jul 7, 2020